GOP Resistance Mounts Against Trump’s Surgeon General Nominee, Exposing MAHA Rift

President Donald Trump’s nominee for surgeon general, Dr. Casey Means, is facing intensifying Republican opposition that has stalled her confirmation and highlighted tensions within the GOP between long‑standing social conservatives and supporters of Robert F. Kennedy Jr.’s Make America Healthy Again (MAHA) movement.

Why The Nomination Is Stalled

Means’ nomination was already in trouble after Senate questions about her positions on vaccines. Since her confirmation hearing, opposition has broadened: anti‑abortion groups criticized her comments on the abortion drug mifepristone, and law‑and‑order conservatives have raised concerns over her past advocacy for therapeutic use of psychedelics.

Abortion-Related Objections

The Ethics and Religious Liberty Commission, the policy arm of the Southern Baptist Convention, urged senators on the Senate Health Committee to oppose Means after she declined during testimony to endorse a federal requirement for an in‑person doctor visit to prescribe mifepristone, saying that issue is largely "out of the purview of the surgeon general's office." Anti‑abortion leaders say that equivocation undermines confidence in her commitment to pro‑life priorities.

Psychedelics And Public-Safety Concerns

Means has written and spoken in favor of the "intentional, guided" therapeutic use of psilocybin and has described positive personal experiences. That stance, along with MAHA’s broader push to broaden access to certain psychedelics, has drawn criticism from conservatives who argue the surgeon general should be a steady, evidence‑based voice on public‑safety and drug issues. Organizations tied to former Vice President Mike Pence have actively lobbied against her confirmation on those grounds.

Senate Dynamics And White House Signals

Three Republican senators on the Senate Health, Education, Labor and Pensions (HELP) Committee — Chair Bill Cassidy, Lisa Murkowski and Susan Collins — have not publicly committed to supporting Means, and Committee action has not been scheduled. A number of other Republican senators are reportedly unwilling to publicly oppose the nomination while votes remain uncertain. The White House has sent mixed messages: the president at one point suggested he might withdraw the nomination, then the administration subsequently invited MAHA leaders to the White House and reaffirmed support.

MAHA Push And Grassroots Response

Health Secretary Robert F. Kennedy Jr. and MAHA advocates are pressing the administration and voting Republicans to back Means. Kennedy has praised her publicly, calling her an articulate advocate for the movement. But efforts to mobilize significant grassroots pressure in the Senate have been limited so far, with some GOP staffers saying outreach has been overshadowed by other priorities, including foreign policy concerns.

"If Republicans had the votes they would have voted already," a Republican Senate aide said, noting that Means lacks a clear floor majority.

The dispute over Means’ nomination is likely to be viewed as a test of MAHA’s influence within the Republican coalition: a rejection would underscore limits on the movement’s reach among traditional conservative constituencies; a confirmation could signal growing openness within the GOP to MAHA priorities on health and drug policy.